digplanet beta 1: Athena
Share digplanet:

Agriculture

Applied sciences

Arts

Belief

Business

Chronology

Culture

Education

Environment

Geography

Health

History

Humanities

Language

Law

Life

Mathematics

Nature

People

Politics

Science

Society

Technology

hypocretin (orexin) receptor 1
Identifiers
Symbol HCRTR1
Entrez 3061
HUGO 4848
OMIM 602392
RefSeq NM_001525
UniProt O43613
Other data
Locus Chr. 1 p33
hypocretin (orexin) receptor 2
Identifiers
Symbol HCRTR2
Entrez 3062
HUGO 4849
OMIM 602393
RefSeq NM_001526
UniProt O43614
Other data
Locus Chr. 6 p11-q11
Orexin receptor type 2
Identifiers
Symbol Orexin_rec2
Pfam PF03827
InterPro IPR004060

The orexin receptor (also referred to as the hypocretin receptor) is a G-protein-coupled receptor that binds the neuropeptide hormone orexin. There are two variants, OX1 and OX2, each encoded by a different gene (HCRTR1, HCRTR2).[1]

Both orexin receptors exhibit a similar pharmacology - the 2 orexin peptides, orexin-A and orexin-B, bind to both receptors and, in each case, agonist binding results in an increase in intracellular calcium levels. However, orexin-B shows a 10-fold selectivity for orexin receptor type 2, whilst orexin-A is equipotent at both receptors.[2]

Several orexin receptor antagonists are in development for potential use in sleep disorders.

References [edit]

  1. ^ Spinazzi R, Andreis PG, Rossi GP, Nussdorfer GG (2006). "Orexins in the regulation of the hypothalamic-pituitary-adrenal axis". Pharmacol. Rev. 58 (1): 46–57. doi:10.1124/pr.58.1.4. PMID 16507882. 
  2. ^ Smart D, Jerman JC, Brough SJ, Rushton SL, Murdock PR, Jewitt F, Elshourbagy NA, Ellis CE, Middlemiss DN, Brown F (September 1999). "Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell-line using FLIPR". Br. J. Pharmacol. 128 (1): 1–3. doi:10.1038/sj.bjp.0702780. PMC 1571615. PMID 10498827. 

External links [edit]

This article incorporates text from the public domain Pfam and InterPro IPR004060


Original courtesy of Wikipedia: http://en.wikipedia.org/wiki/Orexin_receptor — Please support Wikipedia.
A portion of the proceeds from advertising on Digplanet goes to supporting Wikipedia.
13 videos foundNext > 

Partial arrest leading into a full arrest in narcoleptic double orexin receptor knockout mice

IR video recording of a DKO mouse illustrates a partial behavioral arrest that proceeded into a full arrest with considerable rocking. Following the arrest, ...

Devanjan Sikder, Ph.D., D.V.M.

Dr. Sikder of Sanford-Burnham Medical Research Institute investigates the role of orexin in obesity, narcolepsy and cancer.

"i on NIH" - October 2009 vodcast

Featured in this month's episode are segments about a 2009 H1N1 influenza update and a discussion about targeted drug delivery.

Almost 4:20, time for some sunny Dabmarines

Almost 4:20 time for some beer and dab! Dabmarine time! Staying high how about you!? Hahaha Http://www.facebook.com/nick.weedwizard Http://www.nick420ca.spre...

Narcoleptic mice exhibiting partial arrests, as observed in humans and in the canine model.

IR video recording of a DKO mouse illustrates incomplete behavioral arrests that resolves without entering into a full arrest. It appears that movement is im...

Will 'Knockout' Mice Make a Knockout Stock? - Morningstar Video

After a strong runup from our recommendation, is it time to take money off the table in Lexicon Pharmaceuticals? For more Morningstar Video, please visit: ht...

Mice with narcoleptic attacks

IR video recording of a DKO mouse whose behavioral arrest is punctuated by multiple epochs of quivering and rocking. Link to the article: http://www.plosone....

Crazy ass mouse

Haha.

FULL ARREST

4-18-12 FULL ARREST. NOVICE TEXAS, LAMAR COUNTY. To those who follow me on YouTube or just browsing videos I would like to thank all of you (especially the o...

WATER BOTTLES

dont know.

13 videos foundNext > 

2 news items

 
NASDAQ
Tue, 28 May 2013 15:34:13 -0700

Approval would make suvorexant the first orexin receptor antagonist to reach the market. However, we note that the insomnia market is highly competitive and genericized especially given the presence of generic versions of Sanofi's ( SNY ) Ambien.

KLEW

Clinical Psychiatry News Digital Network
Thu, 23 May 2013 08:10:13 -0700

If approved, suvorexant, an orexin receptor antagonist, would be the first drug in this class to be approved for insomnia. The FDA usually follows the recommendations of its advisory panels. The manufacturer, Merck Research Laboratories, studied the ...
Loading

Oops, we seem to be having trouble contacting Twitter

Talk About Orexin receptor

You can talk about Orexin receptor with people all over the world in our discussions.

Support Wikipedia

A portion of the proceeds from advertising on Digplanet goes to supporting Wikipedia. Please add your support for Wikipedia!